Marks Gilbert Lynn
Insider trades filed on SEC Form 4, newest first. SEC CIK 0001916940.
- 16
- Form 4 lines on record
- 0
- Purchases (code P)
- 0
- Sales (code S)
- Oct 13, 2026, 7:13 PM ET
- Latest filing
Companies Marks Gilbert Lynn reports for
- AN2 Therapeutics, Inc. ANTX, DirectorLast filed Oct 13, 2026, 5:13 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
- Filed Oct 13, 2026, 5:13 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jul 10, 2026, 7:41 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Apr 10, 2026, 8:53 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:13 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:13 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:13 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Feb 23, 2026, 4:29 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jan 14, 2026, 5:06 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Oct 14, 2025, 4:01 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jul 11, 2025, 6:20 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 23, 2025, 4:51 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Apr 11, 2025, 4:55 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Dec 23, 2024, 6:38 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 16 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner